Dr. Angela James is the Founder and CEO of Diversity Health NetWoRx LLC (DHN). She is an accomplished leader and scientist and has held senior leadership positions across the Biopharmaceutical industry, including Vice President of Clinical Development at iTeos Therapeutics, Head of Clinical Pharmacology at MacroGenics, and Global Clinical Pharmacology Lead and Project Leader at Astellas Pharma US. Her scientific and strategic leadership contributed to the successful approval of XOSPATA® (gilteritinib), a groundbreaking therapy for adults with relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation.

​

Throughout her career, Dr. James has been instrumental in designing and implementing global clinical development strategies that bridge discovery science and patient outcomes. Her expertise spans first-in-human studies, oncology drug development, clinical pharmacology, and regulatory engagement with global health authorities. She is passionate about integrating scientific excellence, diversity, and patient-centered approaches in clinical research.

​

Driven by deeply personal experiences navigating the healthcare system on behalf of her family, Dr. James founded Diversity Health NetWoRx, LLC to address the inequities and barriers that many patients—particularly those from underrepresented communities—face in accessing clinical trials and innovative treatments. The organization focuses on self-advocacy, health literacy, and creating pathways for patients to engage meaningfully in research and care decisions.

​

A recognized leader and mentor in STEM and BioPharma, Dr. James serves as a Board member for the Alzheimer's Association Chicago Chapter and is the Co-Chair of the Board of Directors for Youth Technology Corps, a Chicago-based nonprofit that equips students with real-world STEM and civic skills. She is the Past Chair of Women In Bio (WIB)  Chicago Advisory Board and Past Chair of the Oncology Community for the American Society of Clinical Pharmacology and Therapeutics (ASCPT). 

​

Dr. James earned her Ph.D. in Pharmaceutical Sciences and M.S. in Pharmacometrics from the University of Maryland, Baltimore, and her B.A. in Biology from Rice University.

 

Through her work at Diversity Health NetWoRx, Dr. James continues to bridge the worlds of science, equity, and advocacy—ensuring that every patient has the information, opportunity, and support needed to be seen, heard, and healed.